Subcutaneous fat is more directly measurable but less metabolically active, so peptide studies on it tend to use different endpoints than those used in visceral-fat-focused research
Strengthening the pipeline is the long-term security Im looking for from Novo, and awaiting the headline, Novo acquires XYZ is something Ive been waiting for for a while as an additional de-risking of the company
doi:10.1155/2012/434971, PMID: 22745639 Velu CS, Niture SK, Doneanu CE, Pattabiraman N, Srivenugopal KS (2007) Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress
It is concerned with the mechanism of peptide selectivity and receptor signaling without insinuating the effects in humans and effects of therapy
Standard cycle structure: On cycle: 8-12 weeks of daily dosing Off cycle: 4 weeks without GHRP-6 (Mod GRF 1-29 can be continued during off-cycle if desired) Repeat Some researchers run longer cycles of 16-20 weeks, particularly when GHRP-6 is part of a structured peptide cycle